Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.

Journal of affective disorders - 1 Apr 2015

Colle Romain, Gressier Florence, Verstuyft Céline, Deflesselle Eric, Lépine Jean-Pierre, Ferreri Florian, Hardy Patrick, Guilloux Jean-Philippe, Petit Anne-Cécile, Fève Bruno, Falissard Bruno, Becquemont Laurent, Corruble Emmanuelle

Abstract excerpt

BACKGROUND: Whether the Brain Derived Neurotrophic Factor (BDNF) Val66Met polymorphism can predict antidepressant drug efficacy in depressed patients remains unclear, suggesting that it may depend on antidepressant classes. We assessed the impact of Val66Met polymorphism on antidepressant response and remission depending on antidepressant classes. METHODS: In a 6-month prospective, real-world setting, treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Brain-Derived Neurotrophic Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Heterozygote

Share to Homozygote

Share to Remission Induction

Share to White People

Share to Young Adult

Source

Identifiers

PMID: 25658497
DOI: 10.1016/j.jad.2015.01.013

Genes

BDNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.PMID 25658497Read ↗

Brain-derived neurotrophic factor Val66Met polymorphism and remission after antidepressant treatment in depressed Caucasian patients: a meta-analysis.Semantic proximity Read ↗

BDNF Val66Met genotype and 6-month remission rates in late-life depression.Semantic proximity Read ↗

Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.Semantic proximity Read ↗

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.Semantic proximity Read ↗

Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis.Semantic proximity Read ↗

Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.Semantic proximity Read ↗

The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression.Semantic proximity Read ↗

Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.Semantic proximity Read ↗

Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression.Semantic proximity Read ↗

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.Semantic proximity Read ↗

Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.Semantic proximity Read ↗

BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.